Jurgen Sota

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Jurgen Sota, Antonella Insalaco, Rolando Cimaz et al. · Frontiers in Pharmacology · 2019 · 616 citations · Full text

Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study

Claudia Fabiani, Antonio Vitale, Ida Orlando et al. · Internal and Emergency Medicine · 2017 · 82 citations

Quality Of Life, Life Assessment, Disease Mechanism +8

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients

Claudia Fabiani, Antonio Vitale, Donato Rigante et al. · Clinical Rheumatology · 2018 · 65 citations

Rheumatology, Medicine, Immunology +6

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Gian Marco Tosi, Jurgen Sota, Antonio Vitale et al. · PubMed · 2019 · 59 citations

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet’s Disease

Claudia Fabiani, Antonio Vitale, Donato Rigante et al. · Ocular Immunology and Inflammation · 2018 · 52 citations